Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02230306
Title Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases
Acronym CoBRIM-B
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hussein Tawbi
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Harriet Kluger New Haven Connecticut 06510 United States Details
Mohammed Milhem, MD Iowa City Iowa 52242 United States Details
Anna Pavlick, MD New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Ravi Amaravadi, MD Philadelphia Pennsylvania 19104 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field